Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937 by Hoffmann, D, Pilotte, L, Stroobant, V, Van Den Eynde, B

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism by Canè, S, Van Snick, J, Uyttenhove, C, Pilotte, L, Van den Eynde, BJ

IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids: Wakayin and Tsitsikammamines by Levy, T, Marchand, L, Stroobant, V, Pilotte, L, Van den Eynde, B, Rodriguez, F, Delfourne, E

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. by Hennequart, M, Pilotte, L, Cane, S, Hoffmann, D, Stroobant, V, Plaen, E, Van den Eynde, B

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance by Hennequart, M, Pilotte, L, Cane, S, Hoffmann, D, Stroobant, V, De Plaen, E, Van Den Eynde, BJ

Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase by Klaessens, S, Stroobant, V, Hoffmann, D, Gyrd-Hansen, M, Pilotte, L, Vigneron, N, De Plaen, E, Van den Eynde, BJ

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors by Schramme, F, Crosignani, S, Frederix, K, Hoffmann, D, Pilotte, L, Stroobant, V, Preillon, J, Driessens, G, Van Den Eynde, B

Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase by Kozlova, A, Thabault, L, Dauguet, N, Deskeuvre, M, Stroobant, V, Pilotte, L, Liberelle, M, Van den Eynde, B, Frédérick, R

Rational design of original fused-cycle selective inhibitors of tryptophan 2,3-dioxygenase by Kozlova, A, Thabault, L, Liberelle, M, Klaessens, S, Prévost, JRC, Mathieu, C, Pilotte, L, Stroobant, V, Van den Eynde, B, Frédérick, R

Apolipoproteins L control cell death triggered by TLR3/TRIF signaling in dendritic cells. by Uzureau, S, Coquerelle, C, Vermeiren, C, Uzureau, P, Van Acker, A, Pilotte, L, Monteyne, D, Acolty, V, Vanhollebeke, B, Van den Eynde, B, Pérez-Morga, D, Moser, M, Pays, E

Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes by Solvay, M, Holfelder, P, Klaessens, S, Pilotte, L, Stroobant, V, Lamy, J, Naulaerts, S, Spillier, Q, Frédérick, R, De Plaen, E, Sers, C, Opitz, CA, Van den Eynde, BJ, Zhu, J

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes. by Orabona, C, Mondanelli, G, Pallotta, MT, Carvalho, A, Albini, E, Fallarino, F, Vacca, C, Volpi, C, Belladonna, ML, Berioli, MG, Ceccarini, G, Esposito, SM, Scattoni, R, Verrotti, A, Ferretti, A, De Giorgi, G, Toni, S, Cappa, M, Matteoli, MC, Bianchi, R, Matino, D, Iacono, A, Puccetti, M, Cunha, C, Bicciato, S, Antognelli, C, Talesa, VN, Chatenoud, L, Fuchs, D, Pilotte, L, Van den Eynde, B, Lemos, MC, Romani, L, Puccetti, P, Grohmann, U